Emergent BioSolutions
EBS
#6766
Rank
$0.63 B
Marketcap
$11.90
Share price
-1.24%
Change (1 day)
30.05%
Change (1 year)

Emergent BioSolutions (EBS) - Total debt

Total debt on the balance sheet as of September 2025 : $0.66 Billion USD

According to Emergent BioSolutions 's latest financial reports the company's total debt is $0.66 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Emergent BioSolutions - Total debt on balance sheet (from 2004 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$0.66 B-22.84%
2023-12-31$0.86 B-38.81%
2022-12-31$1.40 B67.16%
2021-12-31$0.84 B-3.86%
2020-12-31$0.87 B7.83%
2019-12-31$0.81 B2.1%
2018-12-31$0.79 B5785.93%
2017-12-31$13.5 M-94.96%
2016-12-31$0.26 B8.59%
2015-12-31$0.24 B-1.64%
2014-12-31$0.25 B304.84%
2013-12-31$62 M-1.23%
2012-12-31$62.77 M5.58%
2011-12-31$59.45 M25.36%
2010-12-31$47.42 M-27.83%
2009-12-31$65.71 M14.93%
2008-12-31$57.18 M-1.3%
2007-12-31$57.93 M35.45%
2006-12-31$42.77 M259.12%
2005-12-31$11.91 M-7.44%
2004-12-31$12.86 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Merck
MRK
$41.37 B 6,139.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
$0.58 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$23.86 B 3,498.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
$2.62 M-99.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$60.84 B 9,076.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$17.07 B 2,474.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
$0.38 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA